Evropska unija - slovenščina - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastična sredstva - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

celgene europe bv - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Evropska unija - slovenščina - EMA (European Medicines Agency)

celgene europe ltd. - lepirudin - thromboembolism; thrombocytopenia - antitrombotična sredstva - antikoagulacijo pri odraslih bolnikih s heparinom povzročene trombocitopenije tipa ii in trombemboličnih bolezni, obveznost parenteralne terapije. diagnoza mora biti potrjena z heparina-induced trombocitov aktiviranje testa ali enakovredno test.

Evropska unija - slovenščina - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - thalidomide - multiple myeloma - imunosupresivi - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Evropska unija - slovenščina - EMA (European Medicines Agency)

celgene europe ltd. - romidepsin - limfom, non-hodgkin - antineoplastična sredstva - zdravljenje periferne t-celični limfom (ptcl),.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

generics (uk) ltd. - escitalopram - filmsko obložena tableta - escitalopram 10 mg / 1 tableta - escitalopram

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

generics (uk) ltd. - escitalopram - filmsko obložena tableta - escitalopram 5 mg / 1 tableta - escitalopram

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

generics (uk) ltd. - escitalopram - filmsko obložena tableta - escitalopram 10 mg / 1 tableta - escitalopram

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

generics (uk) ltd. - escitalopram - filmsko obložena tableta - escitalopram 5 mg / 1 tableta - escitalopram